Department of Emergency Medicine, Taipei-Veterans General Hospital, Institute of Emergency and Critical Care Medicine, National Yang-Ming University, Taipei, 11217, Taiwan.
Intern Med J. 2012 Jun;42(6):651-7. doi: 10.1111/j.1445-5994.2011.02684.x.
Adverse drug events (ADE) have been studied widely in hospitalised and emergency department (ED) patients. Less is known about the ED visits of drug-related injury in Taiwan. This study seeks to determine the incidence, risk and patient outcomes of ADE in an ED population.
We conducted a prospective observational cohort study of patients 18 years and older presenting to the ED of an urban, tertiary medical centre. ED visits between 1 March 2009 and 28 February 2010 identified by investigators for suspected ADE were further assessed by using the Naranjo Adverse Drug Reaction probability scale. Outcomes (ED disposition, injury severity and preventability) and associated variables (triage, gender, drug category, number of drugs, Charlson comorbidity index score and ADE mechanism) were measured.
Of 58,569 ED visits, 452 patients (0.77%) had physician-documented ADE. 24% of patients with ADE were hospitalised with life-threatening conditions, with a mortality rate of 10.0%. The majority of ADE were considered preventable (73.4%), and the unintentional overdose was the most common cause. Cardiovascular agents accounted for the most ADE (25.8%) and consisted of 65.3% of ADE in patients aged 65,years and older. Risk factors for ADE-related hospitalisation were elderly age (odds ratio (OR) 1.9, 95% confidence interval (CI) 1.1-3.4), severity of ADE (OR 6.9, 95% CI 3.3-14.5) and higher Charlson comorbidity index scores (OR 3.4, 95% CI 2.0-5.7).
ADE-related ED visits are not uncommon in Taiwan and many cases are preventable. ED-based surveillance may provide useful information for monitoring outpatient ADE.
药物不良反应(ADE)在住院患者和急诊科(ED)患者中已得到广泛研究。在台湾,有关与药物相关的 ED 就诊中药物损伤的了解较少。本研究旨在确定 ED 人群中 ADE 的发生率、风险和患者结局。
我们对一家城市三级医疗中心的 18 岁及以上的 ED 就诊患者进行了前瞻性观察性队列研究。由研究者确定疑似 ADE 的 ED 就诊,并使用 Naranjo 药物不良反应概率量表进行进一步评估。结局(ED 处置、损伤严重程度和可预防程度)和相关变量(分诊、性别、药物类别、药物数量、Charlson 合并症指数评分和 ADE 机制)。
在 58569 次 ED 就诊中,有 452 名患者(0.77%)有医生记录的 ADE。24%的 ADE 患者有危及生命的情况,死亡率为 10.0%。大多数 ADE 被认为是可预防的(73.4%),最常见的原因是意外过量用药。心血管药物占 ADE 的大多数(25.8%),占 65 岁及以上患者 ADE 的 65.3%。与 ADE 相关的住院治疗的危险因素是年龄较大(比值比(OR)1.9,95%置信区间(CI)1.1-3.4)、ADE 严重程度(OR 6.9,95%CI 3.3-14.5)和更高的 Charlson 合并症指数评分(OR 3.4,95%CI 2.0-5.7)。
在台湾,与 ADE 相关的 ED 就诊并不罕见,许多病例是可预防的。ED 为基础的监测可能为监测门诊 ADE 提供有用的信息。